Metropolitan Life Insurance Company (MetLife)’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,971
Closed -$63.1K 222
2024
Q1
$63.1K Sell
7,971
-1,046
-12% -$8.23K ﹤0.01% 1281
2023
Q4
$74K Hold
9,017
﹤0.01% 1240
2023
Q3
$60.6K Buy
9,017
+535
+6% +$3.37K ﹤0.01% 1295
2023
Q2
$48.9K Buy
8,482
+973
+13% +$5.13K ﹤0.01% 1429
2023
Q1
$30.9K Sell
7,509
-652
-8% -$2.94K ﹤0.01% 1662
2022
Q4
$33.5K Hold
8,161
﹤0.01% 1724
2022
Q3
$32.7K Hold
8,161
﹤0.01% 1742
2022
Q2
$35.4K Buy
+8,161
New +$41.4K ﹤0.01% 1714

Other funds holding AVPT

Metropolitan Life Insurance Company (MetLife)'s AVPT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AvePoint (AVPT) in Q2 2024, closing a stake of 7,971 shares — an estimated $63.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVPT in Q2 2022 and held it in 8 quarters. The position peaked at $74K in Q4 2023. 174 funds tracked by Wall St. Rank hold AVPT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AvePoint position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,971 AvePoint shares in Q2 2024, an estimated $63.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AvePoint in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s AvePoint position peaked at $74K in Q4 2023.
  • 174 funds tracked by Wall St. Rank held AvePoint as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.